nafagrel has been researched along with indomethacin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Homma, M; Ichikawa, Y; Kameda, H; Tojo, T; Yoshida, T | 1 |
| Abe, K; Funakoshi, M; Horiguchi, S; Karibe, A; Katoh, H; Keitoku, M; Kohzuki, M; Nose, M; Okayama, H; Satoh, S; Shirato, K; Suzuki, S; Takeuchi, M; Watanabe, J | 1 |
| Homma, M; Ikeda, Y; Kameda, H; Masashi, A; Yoshida, T | 1 |
| Takami, M; Tsukada, W | 2 |
2 trial(s) available for nafagrel and indomethacin
| Article | Year |
|---|---|
Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
Topics: Adult; Enzyme Inhibitors; Female; Humans; Imidazoles; Indomethacin; Kidney; Lupus Nephritis; Middle Aged; Prostaglandins; Tetrahydronaphthalenes; Thromboxane A2; Thromboxane-A Synthase | 1996 |
Improvement of renal function with selective thromboxane A2 synthetase inhibitor, DP-1904 in lupus nephritis.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Cross-Over Studies; Enzyme Inhibitors; Female; Humans; Imidazoles; Indomethacin; Lupus Nephritis; Male; Tetrahydronaphthalenes; Thromboxane B2; Thromboxane-A Synthase | 1997 |
3 other study(ies) available for nafagrel and indomethacin
| Article | Year |
|---|---|
FMLP actions and its binding sites in isolated human coronary arteries.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Coronary Vessels; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme System; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Imidazoles; Indomethacin; Intramolecular Oxidoreductases; Isomerases; Isometric Contraction; Macrophages; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Prostaglandins; Receptors, Formyl Peptide; Receptors, Immunologic; Receptors, Peptide; RNA, Messenger; Tetrahydronaphthalenes; Thromboxane A2; Thromboxane-A Synthase | 1997 |
Effect of DP-1904, a thromboxane synthetase inhibitor, on antigen- and spasmogen-induced bronchoconstriction in rodents.
Topics: Acetylcholine; Animals; Antigens; Arachidonic Acid; Bradykinin; Bronchoconstriction; Bronchoconstrictor Agents; Enzyme Inhibitors; Guinea Pigs; Histamine; Histamine H1 Antagonists; Imidazoles; Indomethacin; Leukotriene D4; Male; Methacrylates; Platelet Activating Factor; Pyrilamine; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes; Thromboxane-A Synthase | 1999 |
A possible involvement of thromboxane A2 and peptide leukotrienes in hyperresponsiveness of Sephadex-treated rat lung parenchyma.
Topics: Animals; Anti-Asthmatic Agents; Benzoquinones; Dextrans; Dose-Response Relationship, Drug; Enzyme Inhibitors; Eosinophils; Heptanoic Acids; Imidazoles; Indazoles; Indomethacin; Leukotrienes; Lung; Male; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Serotonin; Tetrahydronaphthalenes; Thromboxane A2 | 1999 |